| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Trials |
1Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong Special Administrative Region, The People’s Republic of China and2 Ciphergen Biosystems Inc., Fremont, California
ABSTRACT
Purpose: Nasopharyngeal cancer (NPC) is a common cancer in Hong Kong, and relapse can occur frequently. Using protein chip profiling analysis, we aimed to identify serum biomarkers that were useful in the diagnosis of relapse in NPC.
Experimental Design: Profiling analysis was performed on 704 sera collected from 42 NPC patients, 39 lung cancer patients, 30 patients with the benign metabolic disorder thyrotoxicosis (TX), and 35 normal individuals (NM). Protein profile in each NPC patient during clinical follow up was correlated with the relapse status.
Results: Profiling analysis identified two biomarkers with molecular masses of 11.6 and 11.8 kDa, which were significantly elevated in 22 of 31 (71%) and 21 of 31 (68%) NPC patients, respectively, at the time of relapse (RP) as compared with 11 patients in complete remission (CR; RP versus CR, P = 0.009), 30 TX (RP versus TX, P < 0.001), or 35 NM (RP versus NM, P < 0.001). The markers were also elevated in 16 of 39 (41%) lung cancer patients at initial diagnosis. By tryptic digestion, followed by tandem mass spectrometry fragmentation, the markers were identified as two isoforms of serum amyloid A (SAA) protein. Monitoring the patients longitudinally for SAA level both by protein chip and immunoassay showed a dramatic SAA increase, which correlated with relapse and a drastic fall correlated with response to salvage chemotherapy. Serum SAA findings were compared with those of serum Epstein-Barr virus DNA in three relapsed patients showing a similar correlation with relapse and chemo-response.
Conclusions: SAA could be a useful biomarker to monitor relapse of NPC.
This article has been cited by other articles:
|
|
 |
|
  A.-L. Cheng, W.-G. Huang, Z.-C. Chen, F. Peng, P.-F. Zhang, M.-Y. Li, F. Li, J.-L. Li, C. Li, H. Yi, et al. Identification of Novel Nasopharyngeal Carcinoma Biomarkers by Laser Capture Microdissection and Proteomic Analysis Clin. Cancer Res., January 15, 2008; 14(2): 435 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C.S. Cho, T. T.C. Yip, R. K.C. Ngan, T.-T. Yip, V. N. Podust, C. Yip, H. H.Y. Yiu, V. Yip, W.-W. Cheng, V. W.S. Ma, et al. ProteinChip Array Profiling for Identification of Disease- and Chemotherapy-Associated Biomarkers of Nasopharyngeal Carcinoma Clin. Chem., February 1, 2007; 53(2): 241 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-C. Chan, C.-J. Chen, H.-C. Chu, W.-K. Chang, J.-C. Yu, Y.-J. Chen, L.-L. Wen, S.-C. Huang, C.-H. Ku, Y.-C. Liu, et al. Evaluation of Serum Amyloid A as a Biomarker for Gastric Cancer Ann. Surg. Oncol., January 1, 2007; 14(1): 84 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Hortin The MALDI-TOF Mass Spectrometric View of the Plasma Proteome and Peptidome Clin. Chem., July 1, 2006; 52(7): 1223 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Gutfeld, D. Prus, Z. Ackerman, S. Dishon, R. P. Linke, M. Levin, and S. Urieli-Shoval Expression of Serum Amyloid A, in Normal, Dysplastic, and Neoplastic Human Colonic Mucosa: Implication for a Role in Colonic Tumorigenesis J. Histochem. Cytochem., January 1, 2006; 54(1): 63 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Diamandis and D.-E. van der Merwe Plasma Protein Profiling by Mass Spectrometry for Cancer Diagnosis: Opportunities and Limitations Clin. Cancer Res., February 1, 2005; 11(3): 963 - 965. [Full Text] [PDF]
|
|
|
|
|
|
J. M. Koomen, L. N. Shih, K. R. Coombes, D. Li, L.-c. Xiao, I. J. Fidler, J. L. Abbruzzese, and R. Kobayashi Plasma Protein Profiling for Diagnosis of Pancreatic Cancer Reveals the Presence of Host Response Proteins Clin. Cancer Res., February 1, 2005; 11(3): 1110 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. T.C. Yip, J. W.M. Chan, W. C.S. Cho, T.-T. Yip, Z. Wang, T.-L. Kwan, S. C.K. Law, D. N.C. Tsang, J. K.C. Chan, K.-C. Lee, et al. Protein Chip Array Profiling Analysis in Patients with Severe Acute Respiratory Syndrome Identified Serum Amyloid A Protein as a Biomarker Potentially Useful in Monitoring the Extent of Pneumonia Clin. Chem., January 1, 2005; 51(1): 47 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Diamandis, T. T. C. Yip, R. K. C. Ngan, W. C. S. Cho, J. S. K. Au, S. C. K. Law, and T.-T. Yip Identification of Serum Amyloid A Protein As a Potentially Useful Biomarker for Nasopharyngeal Carcinoma Clin. Cancer Res., August 1, 2004; 10(15): 5293 - 5294. [Full Text] [PDF]
|
|
|
|
|
|
T. C.W. Poon, K.C. A. Chan, P.-C. Ng, R. W.K. Chiu, I. L. Ang, Y.-k. Tong, E. K.O. Ng, F. W.T. Cheng, A. M. Li, E. K.L. Hon, et al. Serial Analysis of Plasma Proteomic Signatures in Pediatric Patients with Severe Acute Respiratory Syndrome and Correlation with Viral Load Clin. Chem., August 1, 2004; 50(8): 1452 - 1455. [Full Text] [PDF]
|
|
|
|
 |
|
 E. P. Diamandis Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool: Opportunities and Potential Limitations Mol. Cell. Proteomics, April 1, 2004; 3(4): 367 - 378. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
